// App-Quantinova.ai

400 : Disease stage and nigrostriatal integrity predict motor progression in individuals with early Parkinson’s disease

Researchers

Presenter

  • H. Jackson

Principal Investigators

  • J. Anzures-Cabrera

  • K. Taylor

  • G. Pagano

Medical Centers

  • N/A

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Parkinson's disease

  • Movement disorders

Biomarkers

  • Monoamine oxidase B

  • MDS-Unified Parkinson's Disease Rating Scale

Drug/Treatment

  • Dopamine hydrochloride

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved